NDC 68788-6364

Lisinopril with Hydrochlorothiazide

Lisinopril And Hydrochlorothiazide

Lisinopril with Hydrochlorothiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is Hydrochlorothiazide; Lisinopril.

Product ID68788-6364_159165bc-c475-4870-98e8-a0db2897e005
NDC68788-6364
Product TypeHuman Prescription Drug
Proprietary NameLisinopril with Hydrochlorothiazide
Generic NameLisinopril And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-03-16
Marketing CategoryANDA / ANDA
Application NumberANDA076265
Labeler NamePreferred Pharmaceuticals Inc.
Substance NameHYDROCHLOROTHIAZIDE; LISINOPRIL
Active Ingredient Strength13 mg/1; mg/1
Pharm ClassesIncreased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68788-6364-3

30 TABLET in 1 BOTTLE, PLASTIC (68788-6364-3)
Marketing Start Date2016-03-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-6364-9 [68788636409]

Lisinopril with Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA076265
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-03-16
Marketing End Date2019-10-21

NDC 68788-6364-1 [68788636401]

Lisinopril with Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA076265
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-03-16
Marketing End Date2019-10-21

NDC 68788-6364-6 [68788636406]

Lisinopril with Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA076265
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-03-16
Marketing End Date2019-10-21

NDC 68788-6364-3 [68788636403]

Lisinopril with Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA076265
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-03-16
Marketing End Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
HYDROCHLOROTHIAZIDE12.5 mg/1

OpenFDA Data

SPL SET ID:6c2853f5-f8ec-4bf3-b3a5-e5e88cb7e05d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197886

    • Pharmacological Class

    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]
    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]

    NDC Crossover Matching brand name "Lisinopril with Hydrochlorothiazide" or generic name "Lisinopril And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0143-1262Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1263Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1264Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    68788-6364Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    68788-7389Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    70518-0081Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    71335-0284Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    43353-800Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    43353-975Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    50090-2086Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    52959-997Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    66267-752Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    66267-751Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    67544-276Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    0185-0152Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0185-0173Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0185-7100Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0378-1012Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0378-2012Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0378-2025Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0591-0860Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0591-0861Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0591-0862Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7577Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7581Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7582Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-236Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-237Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-564LISINOPRIL AND HYDROCHLOROTHIAZIDELISINOPRIL AND HYDROCHLOROTHIAZIDE
    16571-791Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    16571-792Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.